ProQR Therapeutics N.V

NASDAQ:PRQR   3:59:59 PM EDT
5.04
-0.08 (-1.56%)
Debt Financing / Related

ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital

Published: 12/30/2021 13:02 GMT
ProQR Therapeutics N.V (PRQR) - Proqr Announces Amendment to Convertible Debt Financing Agreement With Pontifax Ventures and Kreos Capital.
Proqr Therapeutics NV - Amendment Provides Co With Access to Up to Additional $90 Million in Convertible Debt Financing in 3 New Tranches of $30 Million Each.
Proqr Therapeutics NV - Convertible Debt Financing Will Mature Over a 54 Month Period and Have an Interest-only Period of 33 Months.
Proqr Therapeutics NV - Three New Tranches Replace Two Undrawn Tranches Under Original Convertible Debt Financing Agreement.